travelerstoday.com · DistrictNews · 2026-08-20
Melanoma Vaccine Reaches Phase 3 Milestone : Travel Access May Be Years Away Outside the US
Melanoma vaccine travel access is years away for most patients outside the US. Moderna and Merck’s personalized mRNA cancer vaccine Intismeran passed its first Phase 3 trial, with US approval projected as early as 2027 — but individualized manufacturing will limit global access. What medical Melanoma Vaccine Reaches Phase 3 Milestone : Travel Access May Be Years Away Outside the US
Read original on travelerstoday.com Get the app
Licensed summary · LicensedSummary
Related briefs
- Ahmedabad-Bhagalpur Amrit Bharat Express to start on August 26: Check route, stops and timings
- What is an ‘industry’? Supreme Court to decide scope of key labour law
- Unauthorised structures outside Pakistan High Commission demolished in Delhi
- Two doctors of Mumbai's Parsi community to receive Nishan-e-Imtiaz for keeping secret Jinnah's illness
- India tells UNSC not to use sanctions process for narrow politics